UBS Group’s Tenon Medical Inc Warrant TNONW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5 Buy
499
+399
+399% +$3 ﹤0.01% 10351
2026
Q1
$1 Buy
+100
New +$1 ﹤0.01% 10394
2025
Q2
Sell
-10,500
Closed -$221 10826
2025
Q1
$221 Buy
10,500
+7,834
+294% +$161 ﹤0.01% 9876
2024
Q4
$35 Buy
2,666
+1,805
+210% +$38 ﹤0.01% 9737
2024
Q3
$26 Buy
+861
New +$40 ﹤0.01% 9291
2023
Q4
Sell
-31,631
Closed -$1.3K 9890
2023
Q3
$1.3K Buy
+31,631
New +$2.32K ﹤0.01% 7995

Other funds holding TNONW

UBS Group's TNONW Position: Q2 2026 in Review

UBS Group increased its Tenon Medical Inc Warrant (TNONW) stake by 399% in Q2 2026, buying an estimated $3 and bringing the position to 499 shares worth $5. The position accounts for ﹤0.01% of the portfolio, ranked #10351.

UBS Group first reported a position in TNONW in Q3 2023 and has held it in 6 quarters since. The position peaked at $1.3K in Q3 2023. 9 funds tracked by Wall St. Rank hold TNONW as of Q2 2026.

  • UBS Group held 499 shares of Tenon Medical Inc Warrant worth $5 as of Q2 2026.
  • UBS Group bought 399 Tenon Medical Inc Warrant shares in Q2 2026, an estimated $3.
  • Tenon Medical Inc Warrant made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #10351 holding.
  • UBS Group first reported a position in Tenon Medical Inc Warrant in Q3 2023 and has held it in 6 quarters since.
  • UBS Group's Tenon Medical Inc Warrant position peaked at $1.3K in Q3 2023.
  • 9 funds tracked by Wall St. Rank held Tenon Medical Inc Warrant as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.